Beck ES, Cortese I (2020) Checkpoint inhibitors for the treatment of JC virus-related progressive multifocal leukoencephalopathy. Curr Opin Virol 40:19–27

Article  CAS  PubMed  Google Scholar 

Bennett KM, Fernandes PM (2020) Novel treatments for progressive multifocal leukoencephalopathy. Br J Hosp Med 81:1–9

Google Scholar 

Bernard-Valnet R, Koralnik IJ, Du Pasquier R (2021) Advances in treatment of progressive multifocal leukoencephalopathy. Ann Neurol 90:865–873

Article  PubMed  PubMed Central  Google Scholar 

Beudel M, Rövekamp F, van de Beek D, Brouwer M (2021) Single-dose pembrolizumab treatment for progressive multifocal leukoencephalopathy. Neurol Neuroimmunol Neuroinflamm 8:e1021

Article  PubMed  PubMed Central  Google Scholar 

Boumaza X, Bonneau B, Roos-Weil D, Pinnetti C, Rauer S, Nitsch L, Del Bello A, Jelcic I, Sühs KW, Gasnault J, Goreci Y, Grauer O, Gnanapavan S, Wicklein R, Lambert N, Perpoint T, Beudel M, Clifford D, Sommet A, Cortese I, Martin-Blondel G (2023) Progressive multifocal leukoencephalopathy treated by immune checkpoint inhibitors. Ann Neurol 93:257–270

Article  CAS  PubMed  Google Scholar 

Chen H, Moussa M, Catalfamo M (2020) The role of immunomodulatory receptors in the pathogenesis of HIV infection: a therapeutic opportunity for HIV cure? Front Immunol 11:1223–1223

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cortese I, Muranski P, Enose-Akahata Y, Ha SK, Smith B, Monaco M, Ryschkewitsch C, Major EO, Ohayon J, Schindler MK, Beck E, Reoma LB, Jacobson S, Reich DS, Nath A (2019) Pembrolizumab treatment for progressive multifocal leukoencephalopathy. N Engl J Med 380:1597–1605

Article  CAS  PubMed  Google Scholar 

Cortese I, Reich DS, Nath A (2021) Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease. Nat Rev Neurol 17:37–51

Article  PubMed  Google Scholar 

Darcy S, Alexander M, McCarthy A, O’Dowd S (2022) Pembrolizumab treatment of inflammatory progressive multifocal leukoencephalopathy: a report of two cases. J Neurovirol 28:145–150

Article  PubMed  Google Scholar 

Fan S, Qiao X, Liu L, Wu H, Zhou J, Sun R, Chen Q, Huang Y, Mao C, Yuan J, Lu Q, Ge Y, Li Y, Ren H, Wang J, Cui L, Zhao W, Guan H (2018) Next-generation sequencing of cerebrospinal fluid for the diagnosis of neurocysticercosis. Front Neurol 9:471

Article  PubMed  PubMed Central  Google Scholar 

Fan S, Ren H, Zhao L, Yin J, Feng G, Wang J, Guan H (2020a) Neurological immune-related adverse events associated with immune checkpoint inhibitors: a review of the literature. Asia Pac J Clin Oncol 16:291–298

Article  PubMed  Google Scholar 

Fan S, Yuan H, Liu L, Li H, Wang S, Zhao W, Wu Y, Wang P, Hu Y, Han J, Lyu Y, Zhang W, Chen P, Wu H, Gong Y, Ma Z, Li Y, Yu J, Qiao X, Li G, Zhao Y, Wang D, Ren H, Peng B, Cui L, Wang J, Guan H (2020b) Pseudorabies virus encephalitis in humans: a case series study. J Neurovirol 26:556–564

Article  CAS  PubMed  Google Scholar 

Gheuens S, Bord E, Kesari S, Simpson DM, Gandhi RT, Clifford DB, Berger JR, Ngo L, Koralnik IJ (2011) Role of CD4+ and CD8+ T cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome. J Virol 85:7256–7263

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grassl N, Bunse L, Beutel T, Klockziem M, Gass A, Platten M, Eisele P (2020) Nivolumab for treatment of progressive multifocal leukoencephalopathy in Sézary syndrome. Eur J Neurol 27:2373–2374

Article  CAS  PubMed  Google Scholar 

Hoang E, Bartlett NL, Goyal MS, Schmidt RE, Clifford DB (2019) Progressive multifocal leukoencephalopathy treated with nivolumab. J Neurovirol 25:284–287

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jubel JM, Barbati ZR, Burger C, Wirtz DC, Schildberg FA (2020) The role of PD-1 in acute and chronic infection. Front Immunol 11:487

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khanna N, Elzi L, Mueller NJ, Garzoni C, Cavassini M, Fux CA, Vernazza P, Bernasconi E, Battegay M, Hirsch HH (2009) Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study. Clin Infect Dis 48:1459–1466

Article  PubMed  Google Scholar 

Küpper C, Heinrich J, Kamm K, Bücklein V, Rothenfusser S, Straube A (2019) Pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiency. Neurol Neuroimmunol Neuroinflamm 6:e628

Article  PubMed  PubMed Central  Google Scholar 

Lambert N, Dauby S, Dive D, Sadzot B, Maquet P (2022) Atezolizumab treatment for progressive multifocal leukoencephalopathy. Emerg Infect Dis 28:253–256

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lambert N, El Moussaoui M, Maquet P (2021) Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: identifying relevant outcome factors. Eur J Neurol 28:3814–3819

Article  PubMed  Google Scholar 

Mahler C, Andrews M, Henson SM, Gnanapavan S (2020) Sequential interleukin 2 and pembrolizumab use in progressive multifocal leukoencephalopathy. Neurol Neuroimmunol Neuroinflamm 7:e756

Article  PubMed  PubMed Central  Google Scholar 

Major EO, Yousry TA, Clifford DB (2018) Pathogenesis of progressive multifocal leukoencephalopathy and risks associated with treatments for multiple sclerosis: a decade of lessons learned. Lancet Neurol 17:467–480

Article  CAS  PubMed  Google Scholar 

Martinot M, Ahle G, Petrosyan I, Martinez C, Gorun DM, Mohseni-Zadeh M, Fafi-Kremer S, Tebacher-Alt M (2018) Progressive multifocal leukoencephalopathy after treatment with nivolumab. Emerg Infect Dis 24:1594–1596

Article  PubMed  PubMed Central  Google Scholar 

Möhn N, Wattjes MP, Adams O, Nay S, Tkachenko D, Salge F, Heine J, Pars K, Höglinger G, Respondek G, Stangel M, Skripuletz T, Jacobs R, Sühs KW (2021) PD-1-inhibitor pembrolizumab for treatment of progressive multifocal leukoencephalopathy. Ther Adv Neurol Disord 14:1756286421993684

Article  PubMed  PubMed Central  Google Scholar 

Pinnetti C, Cimini E, Vergori A, Mazzotta V, Grassi G, Mondi A, Forbici F, Amendola A, Grisetti S, Baldini F, Candela C, Casetti R, Campioni P, Capobianchi MR, Agrati C, Antinori A (2022) Use of pembrolizumab for treatment of progressive multifocal leukoencephalopathy in people living with HIV. Viruses 14:970

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roos-Weil D, Weiss N, Guihot A, Uzunov M, Bellanger A, Eymard B, Saadoun D, Houillier C, Idbaih A, Demeret S, Deback C, Leblond V, Galanaud D, Shor N, Pourcher V (2021) Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: a new gold standard? J Neurol 268:2458–2465

Article  CAS  PubMed  Google Scholar 

Sanjo N, Nose Y, Shishido-Hara Y, Mizutani S, Sekijima Y, Aizawa H, Tanizawa T, Yokota T (2019) A controlled inflammation and a regulatory immune system are associated with more favorable prognosis of progressive multifocal leukoencephalopathy. J Neurol 266:369–377

Article  CAS  PubMed  Google Scholar 

Vinatier E, Poli C, Giltat A, Nunes-Gomes C, Orvain C, Hunault-Berger M, Jeannin P, Thépot S (2022) Progressive multifocal leukoencephalopathy after durvalumab treatment for acute myeloid leukemia: a consequence of an immune reconstitution inflammatory syndrome? Ejhaem 3:958–961

Article  CAS  PubMed  PubMed Central  Google Scholar 

Volk T, Warnatz K, Marks R, Urbach H, Schluh G, Strohmeier V, Rojas-Restrepo J, Grimbacher B, Rauer S (2021) Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients. J Neurol 269:973–981

Article  PubMed  PubMed Central  Google Scholar 

Walter O, Treiner E, Bonneville F, Mengelle C, Vergez F, Lerebours F, Delobel P, Liblau R, Martin-Blondel G (2019) Treatment of progressive multifocal leukoencephalopathy with nivolumab. N Engl J Med 380:1674–1676

Article  PubMed  Google Scholar 

Wei SC, Duffy CR, Allison JP (2018) Fundamental mechanisms of immune checkpoint blockade therapy. Cancer Discov 8:1069–1086

Article  PubMed  Google Scholar 

Wherry EJ, Kurachi M (2015) Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol 15:486–499

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wykes MN, Lewin SR (2018) Immune checkpoint blockade in infectious diseases. Nat Rev Immunol 18:91–104

Article  CAS  PubMed  Google Scholar